- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/14 - Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
Patent holdings for IPC class C07K 14/14
Total number of patents in this class: 110
10-year publication summary
|
6
|
8
|
3
|
5
|
7
|
8
|
3
|
2
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oncolytics Biotech Inc. | 48 |
8 |
| Novartis AG | 10741 |
5 |
| Intervet International B.V. | 1299 |
5 |
| Intervet Inc. | 910 |
4 |
| Universidade de Santiago de Compostela | 315 |
4 |
| The Regents of the University of California | 19989 |
3 |
| Gavish-galilee Bio Applications Ltd. | 48 |
3 |
| Medicago Inc. | 138 |
3 |
| Merial Limited | 115 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 584 |
3 |
| Modernatx, Inc. | 1259 |
3 |
| North Carolina State University | 1564 |
3 |
| University of Georgia Research Foundation, Inc. | 1033 |
3 |
| Entos Pharmaceuticals Inc. | 38 |
3 |
| BRANDEIS University | 334 |
2 |
| Children's Medical Center Corporation | 1877 |
2 |
| London School of Hygiene & Tropical Medicine | 25 |
2 |
| Osaka University | 3384 |
2 |
| The Trustees of Indiana University | 744 |
2 |
| University of Cape Town | 256 |
2 |
| Other owners | 45 |